We have located links that may give you full text access.
The role of asymptomatic hyperuricemia in the progression of chronic kidney disease CKD and cardiovascular diseases CVD.
Korean Journal of Internal Medicine 2020 October 7
In the past decades, questions arose whether hyperuricemia works as an independent risk factor of cardiovascular and renal disease, many evidence cleared this question, that hyperuricemia works as an independent risk factor for chronic kidney disease and cardiovascular diseases. Hyperuricemia defined as an abnormally high level of uric acid. In general, it's defined as serum urate concentration excess of 6.8 mg/dl. Hyperuricemia, which is commonly thought to be just a complication of chronic kidney disease, seems to play a pathogenic role in the progression of renal diseases. In recent years, more attention has been paid to the link between hyperuricemia and chronic kidney disease. Randomized controlled trials have shown that there may be independent associations between hyperuricemia and the progression of cardiovascular and renal morbidity. It is thought to be mediated by renin-angiotensin system activation, nitric oxide syntheses inhibition, and the development of macro and microvascular diseases. Debate continues regarding serum uric acid concentration as an indirect index of renal vascular disease. To sort out the thread, our literature review focus on the role of asymptomatic hyperuricemia in the progress of chronic kidney disease along with the association between hyperuricemia and cardiovascular diseases and a general review of the physiological metabolism of uric acid.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app